MetaVia

MTVANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$11.068 M

$1.68 +0.60%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$13.0M

Loss-making

Shares outstanding

6,588,101

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#427Vistagen TherapeuticsVTGN$11.2M
#428BullFrog AIBFRG$11.1M
#429MetaViaMTVA$11.1M
#430Adial PharmaceuticalsADIL$11.0M
#431Moleculin BiotechMBRX$11.0M

What if MetaVia were worth as much as…

Open the what-if tool →

Gold $30.2T

$4,589,178

Per share 2,731,654× higher

Bitcoin $1.74T

$264,363.74

Per share 157,359× higher

Nvidia $5.52T

$837,231.68

Per share 498,352× higher

Or at a round number

$20.0M $50.0M $100.0M $200.0M

Where these numbers come from

Share counts and financials for MetaVia are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.